Login

Driving Ambition: Oxford Metrics features Chris Barnes, CEO of Tracsis Plc, segment by Cavendish 00:10:00

Share On Facebook Share On Twitter

Imogen Moorhouse is CEO/Exec Dir at Oxford Metrics PLC. 

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:00:00
Scancell Holdings' present progression and pipeline plan now firm is fully funded for all programmes - Professor Lindy Durrant (Chief Executive Officer, Chief Scientific Officer), Scancell Holdings
00:10:00
Revolutionizing Art Investment Through Technology, Transparency, and Blue-Chip Access|Tony Dalwood,CEO,Gresham House Ventures
00:10:00
Innovations in Investment Strategy: PFM Asset Management LLC Presentation on March 27, 2023
00:10:00
Thomas Peterffy, Chairman of Interactive Brokers, discusses the company's quarterly earnings on "Closing Bell Overtime."
00:10:00
Gold Royalty: Building a Scalable, Mid-Tier Company with Inflation-Protected Revenue
00:10:00
Leading Through Change: Hanneke Smits on COVID's Impact, Diversity, and Career Transitions| Hanneke Smits, CEO , The Bank of New York Mellon Corporation.
00:10:00
Exploring Private Equity and Alternative Investments with Thys van Zyl | Thys van Zyl, CEO, Everest Wealth Management, LLC.
00:10:00
Aston Minerals (ASO) Targets Enhanced Nickel Recovery Rates to Boost Production Efficiency | Dale Ginn, Managing Director, Aston Minerals Ltd.
00:10:00
John Lindfors Discusses DST Global's Strategic Vision and Investment Philosophy | John Lindfors, Co-Founder, DST Global.
00:10:00
Eric led investments in enterprise software companies such as Confluent and Amplitude, both of which IPO'ed in 2021. 
00:10:00
Vision Lithium's Quebec Project: Quick Profit Potential Through Direct Ore Sales
00:10:00
David Bramhill on Union Jack Oil's Expansion, US Success, and UK Asset Strength | David Bramhill, Executive Chairman, Union Jack Oil Plc.

© 2017 - Neuhu+